Literature DB >> 34246476

Insulin Sensitivity After Living Donor Nephrectomy.

Bekir Tanriover1, Ildiko Lingvay2, Firas Ahmed3, Burhaneddin Sandikci4, Sumit Mohan5, Serge Cremers6, Wahida Karmally6, Prince Mohan7, Jeffrey Newhouse2, Sneha Ragunathan8, Nashila AbdulRahim9, Venkatesh K Ariyamuthu10, Lloyd E Ratner11, David J Cohen5.   

Abstract

BACKGROUND: The kidney is essential for glucose and insulin metabolism. Living kidney donors (LKDs) experience a reduction in glomerular filtration rate of 25 to 30 mL/min after donor nephrectomy. Little is known about the effect of glomerular filtration rate decline on insulin sensitivity in LKDs.
METHODS: We conducted a prospective pilot study on 9 LKDs (N = 9) who underwent dynamic metabolic testing (mixed meal tolerance test) to measure proxies of insulin sensitivity (homeostatic model assessment of insulin resistance, the area under curve [AUC] for insulin/glucose ratio, and Matsuda insulin sensitivity index) before and 3 months after donor nephrectomy. The primary outcome was the change in insulin sensitivity indices (delta [post-nephrectomy - pre-nephrectomy]).
RESULTS: Four of the donors had a body mass index (BMI) between 32.0 and 36.7 predonation. Post-donor nephrectomy, compared with prenephrectomy values, median insulin AUC increased from 60.7 to 101.7 hr*mU/mL (delta median 33.3, P = .04) without significant change in median glucose AUC levels from 228.9 to 209.3 hr*mg/dL (delta median 3.2, P = .77). There was an increase in the median homeostatic model assessment of insulin resistance from 2 to 2.9 (delta median 0.8, P = .03) and the AUC insulin/glucose ratio from 30.9 to 62.1 pmol/mmol (delta median 17.5, P = .001), whereas the median Matsuda insulin sensitivity index decreased from 5.9 to 2.9 (delta median -2, P = .05). The changes were more pronounced in obese (BMI >32) donors.
CONCLUSION: LKDs appear to have a trend toward a decline in insulin sensitivity post-donor nephrectomy in the short term, especially in obese donors (BMI >32). Further investigation with a larger sample size and longer follow-up is needed.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34246476      PMCID: PMC8384711          DOI: 10.1016/j.transproceed.2021.06.007

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.014


  29 in total

Review 1.  The metabolic syndrome: a global public health problem and a new definition.

Authors:  Paul Zimmet; Dianna Magliano; Yuji Matsuzawa; George Alberti; Jonathan Shaw
Journal:  J Atheroscler Thromb       Date:  2005       Impact factor: 4.928

2.  Longitudinal decline of β-cell function: comparison of a direct method vs a fasting surrogate measure: the Insulin Resistance Atherosclerosis Study.

Authors:  A Festa; S M Haffner; L E Wagenknecht; C Lorenzo; A J G Hanley
Journal:  J Clin Endocrinol Metab       Date:  2013-07-24       Impact factor: 5.958

3.  Weight gain after kidney donation: Association with increased risks of type 2 diabetes and hypertension.

Authors:  Naim Issa; Otto A Sánchez; Aleksandra Kukla; Samy M Riad; Danielle M Berglund; Hassan N Ibrahim; Arthur J Matas
Journal:  Clin Transplant       Date:  2018-08-18       Impact factor: 2.863

Review 4.  Should living kidney donor candidates with impaired fasting glucose donate?

Authors:  Christine Buchek Vigneault; William Stuart Asch; Neera Kanhouwa Dahl; Margaret Johnson Bia
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

5.  The effect of laparoscopic cholecystectomy on insulin sensitivity.

Authors:  G C Hawthorne; L Ashworth; K G Alberti
Journal:  Horm Metab Res       Date:  1994-10       Impact factor: 2.936

6.  Susceptibility to insulin resistance after kidney donation: a pilot observational study.

Authors:  Walid Shehab-Eldin; Sabry Shoeb; Said Khamis; Yassien Salah; Ahmed Shoker
Journal:  Am J Nephrol       Date:  2009-07-31       Impact factor: 3.754

7.  Lifetime risk for diabetes mellitus in the United States.

Authors:  K M Venkat Narayan; James P Boyle; Theodore J Thompson; Stephen W Sorensen; David F Williamson
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

8.  OPTN/SRTR 2018 Annual Data Report: Kidney.

Authors:  A Hart; J M Smith; M A Skeans; S K Gustafson; A R Wilk; S Castro; J Foutz; J L Wainright; J J Snyder; B L Kasiske; A K Israni
Journal:  Am J Transplant       Date:  2020-01       Impact factor: 8.086

9.  Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK.

Authors:  Mandeep P Gaidhu; Nicole M Anthony; Prital Patel; Thomas J Hawke; Rolando B Ceddia
Journal:  Am J Physiol Cell Physiol       Date:  2010-01-27       Impact factor: 4.249

10.  Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.

Authors:  Carla J Greenbaum; Thomas Mandrup-Poulsen; Paula Friedenberg McGee; Tadej Battelino; Burkhard Haastert; Johnny Ludvigsson; Paolo Pozzilli; John M Lachin; Hubert Kolb
Journal:  Diabetes Care       Date:  2008-07-15       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.